| ²é¿´: 554 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
СÍèÍè9Ìú³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
Çó·ÒëÒ»¾ä»°£¬Ð»Ð»
|
|
|
The studies are being conducted in a patient population at risk for CV clinical events. Primary endpoints are clinical endpoints or prevention of arrhythmias in post-MI patients; Tg-lowering is not an efficacy measure |
» ²ÂÄãϲ»¶
Сľ³æÃ»ÂäÁË£¬³ýÁËÆíµ»Ìû×Ó£¬¼¸ºõ¿´²»µ½ÓмÛÖµµÄÌû×Ó
ÒѾÓÐ15È˻ظ´
ÃæÉϵÄË®ºÜÉî
ÒѾÓÐ18È˻ظ´
¹úÉç¿ÆÍ¨Ñ¶ÆÀÉó
ÒѾÓÐ5È˻ظ´
5¸ö%2F£¬·Ç¹Ì¶¨¶Î22¸ö×Öĸ
ÒѾÓÐ9È˻ظ´
ÉúÃü¿ÚC13ÃæÉÏ»áÆÀʱ¼ä
ÒѾÓÐ11È˻ظ´
ÄÚÐÄØÑ·¦
ÒѾÓÐ16È˻ظ´
ÉúÃü¿ÚÃæÉÏ»áÆÀ½áÊøÁËÂð´ó¼ÒÓÐÖªµÀ½á¹ûÂð£¿ÏÖÔÚ»¹Ã»Óнá¹ûÕý³£²»£¿
ÒѾÓÐ9È˻ظ´
ͶӢÎÄÆÚ¿¯ÈçºÎ²éÖØ
ÒѾÓÐ6È˻ظ´
²»ÒªÔÙÊý¹ú×ÔÈ»ÉêÇëÊéµÄ filecode µÄ·Ö¸ô·û¸öÊýÁË
ÒѾÓÐ21È˻ظ´
²®°·Éϼ׻ùÇóÖú
ÒѾÓÐ7È˻ظ´

ssssllllnnnn
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
Translator and Proofreader
- ·ÒëEPI: 1690
- Ó¦Öú: 452 (˶ʿ)
- ½ð±Ò: 31580.9
- ºì»¨: 100
- Ìû×Ó: 7681
- ÔÚÏß: 19966.6Сʱ
- ³æºÅ: 3328089
- ×¢²á: 2014-07-17
- רҵ: Ö×Áö·¢Éú
2Â¥2015-08-24 11:34:49











»Ø¸´´ËÂ¥
10